Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

37.32
-0.0800-0.21%
Post-market: 37.320.00000.00%19:59 EDT
Volume:10.26M
Turnover:383.44M
Market Cap:166.63B
PE:9.32
High:37.65
Open:37.64
Low:37.17
Close:37.40
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.79
T/O Rate:0.32%
Dividend:1.79
Dividend Rate:4.78%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.12
PE(LYR):10.31

Loading ...

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Aug 25

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Aug 25

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Aug 25

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 24

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027

Reuters
·
Aug 20

Moderately bullish activity in Novo Nordisk with shares up 1.32%

TIPRANKS
·
Aug 20

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

TIPRANKS
·
Aug 20

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Novo-Nordisk A/S Rises 3.02% in Regular Trading, Launches Low-Dose Oral Weight Loss Drug Clinical Trial

Market Focus
·
Aug 19

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

TIPRANKS
·
Aug 19

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

Dow Jones
·
Aug 19

Novo Nordisk Launches Dosage Study for Oral Semaglutide

MT Newswires Live
·
Aug 19

Novo Nordisk Tests Semaglutide’s Alzheimer’s Potential: What Investors Should Watch

TIPRANKS
·
Aug 19

BMO Capital Remains a Hold on Novo Nordisk (NVO)

TIPRANKS
·
Aug 18

Novo Nordisk Lawsuit Ruling Lets Some Securities Claims Move Forward

TIPRANKS
·
Aug 18